What are the possible side effects of Keta-Hameln?
Along with its needed effects, a medicine may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.
Check with your doctor or nurse immediately if any of the following side effects occur:
Incidence not known
Bloody or cloudy urine
bluish lips or skin
blurred or change in vision
burning while urinating
chest pain, discomfort, or tightness
confusion as to time, place, or person
difficult, burning, or painful urination
difficulty with swallowing
dizziness, faintness, or lightheadedness when getting up suddenly from a lying or sitting position
fast, slow, or irregular heartbeat
frequent urge to urinate
hives, itching, skin rash
holding false beliefs that cannot be changed by fact
irregular, fast or slow, or shallow breathing
loss of vision
pale or blue lips, fingernails, or skin
puffiness or swelling of the eyelids or around the eyes, face, lips, or tongue
seeing, hearing, or feeling things that are not there
unusual excitement, nervousness, or restlessness
unusual tiredness or weakness
Some side effects may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects. Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:
Incidence not known
flushing or redness of the skin
loss of appetite
pain at the injection site
uncontrolled eye movements
unusually warm skin
Other side effects not listed may also occur in some patients. If you notice any other effects, check with your healthcare professional.
Call your doctor for medical advice about side effects. You may report side effects to the FDA at 1-800-FDA-1088.
Keta-Hameln side effects (in more detail)
Side effects of Keta-Hameln in details
A side effect of any drug can be defined as the unwanted or undesired effect produced by the drug. The side effect can be major or in few medications minor that can be ignored. Side effects not only vary from drug to drug, but it also depends on the dose of the drug, the individual sensitivity of the person, brand or company which manufactures it. If side effects overweigh the actual effect of the medicine, it may be difficult to convince the patient to take the drug. Few patients get specific side effects to specific drugs; in that case, a doctor replaces the drug with another. If you feel any side effect and it troubles you, do not forget to share with your healthcare practitioner.
Cardiovascular: Blood pressure and pulse rate are frequently elevated following administration of Keta-Hameln hydrochloride alone. However, hypotension and bradycardia have been observed. Arrhythmia has also occurred.
Respiration: Although respiration is frequently stimulated, severe depression of respiration or apnea may occur following rapid intravenous administration of high doses of Keta-Hameln hydrochloride. Laryngospasms and other forms of airway obstruction have occurred during Keta-Hameln hydrochloride anesthesia.
Eye: Diplopia and nystagmus have been noted following Keta-Hameln hydrochloride administration. It also may cause a slight elevation in intraocular pressure measurement.
Genitourinary: Severe irritative and inflammatory urinary tract and bladder symptoms including cystitis have been reported in individuals with history of chronic Keta-Hameln use or abuse.
Neurological: In some patients, enhanced skeletal muscle tone may be manifested by tonic and clonic movements sometimes resembling seizures.
Gastrointestinal: Anorexia, nausea and vomiting have been observed; however, this is not usually severe and allows the great majority of patients to take liquids by mouth shortly after regaining consciousness.
General: Anaphylaxis. Local pain and exanthema at the injection site have infrequently been reported. Transient erythema and/or morbilliform rash have also been reported.
For medical advice about adverse reactions contact your medical professional. To report SUSPECTED ADVERSE REACTIONS, contact JHP at 1-866-923-2547 or MEDWATCH at 1-800-FDA-1088 (1- 800-332-1088) or http://www.fda.gov/medwatch/.
Drug Abuse And Dependence
Keta-Hameln has been reported being used as a drug of abuse.
Reports suggest that Keta-Hameln produces a variety of symptoms including, but not limited to anxiety, dysphoria, disorientation, insomnia, flashbacks, hallucinations, and psychotic episodes.
Keta-Hameln dependence and tolerance are possible following prolonged administration. A withdrawal syndrome with psychotic features has been described following discontinuation of long-term Keta-Hameln use. Therefore, Keta-Hameln should be prescribed and administered with caution.
What is the most important information I should know about Keta-Hameln?
Keta-Hameln may cause drowsiness for up to 24 hours. These effects may be worse if you take it with alcohol or certain medicines. Use Keta-Hameln with caution. Do not drive or perform other possibly unsafe tasks for at least 24 hours following surgery until you know how you react to it.
Keta-Hameln may cause behavior, mental, or mood changes; confusion; or hallucinations that usually go away within 24 hours. Discuss any questions or concerns with your doctor.
Tell your doctor or dentist that you take Keta-Hameln before you receive any medical or dental care, emergency care, or surgery.
Use Keta-Hameln with caution in the ELDERLY; they may be more sensitive to its effects.
Keta-Hameln should be used with extreme caution in CHILDREN younger than 16 years old; safety and effectiveness in these children have not been confirmed.
PREGNANCY and BREAST-FEEDING: It is not known if Keta-Hameln can cause harm to the fetus. Use of Keta-Hameln during pregnancy is not recommended. If you are or will be breast-feeding while you are using Keta-Hameln, check with your doctor or pharmacist to discuss the risks to your baby.
Contraindication can be described as a special circumstance or a disease or a condition wherein you are not supposed to use the drug or undergo particular treatment as it can harm the patient; at times, it can be dangerous and life threatening as well. When a procedure should not be combined with other procedure or when a medicine cannot be taken with another medicine, it is called Relative contraindication. Contraindications should be taken seriously as they are based on the relative clinical experience of health care providers or from proven research findings.
You should not receive Keta-Hameln if you are allergic to it, or if you have untreated or uncontrolled hypertension (high blood pressure).
Before you receive Keta-Hameln, tell your doctor if you have heart disease, high blood pressure, a history of alcoholism, or if you recently drank large amounts of alcohol.
Keta-Hameln may be harmful to an unborn baby. Tell your doctor if you are pregnant.
You may feel strange or slightly confused when you first come out of anesthesia. Tell your caregivers if these feelings are severe or unpleasant. It may take you longer to recover from anesthesia with Keta-Hameln if you have recently used a barbiturate (Butisol, Mebaral, Seconal, Nembutal, Solfoton, and others) or narcotic medication (Vicodin, Dilaudid, OxyContin, Percocet, Actiq, Duragesic, Methadose, Dolophine, Kadian, MS Contin, and others).
Tell your caregivers at once if you have any of these serious side effects within 24 hours after you receive Keta-Hameln: severe confusion, hallucinations, unusual thoughts, or extreme fear.
This medication may impair your thinking or reactions. You will probably not be allowed to drive yourself home after your surgery or medical procedure. Avoid driving or operating machinery for at least 24 hours after you have received Keta-Hameln.
Call your doctor at once if you have a serious side effect such as slow heart rate, weak or shallow breathing, feeling like you might pass out, pain or burning when you urinate, or jerky muscle movements that may look like convulsions.
DTP/NCI. "ketamine: The NCI Development Therapeutics Program (DTP) provides services and resources to the academic and private-sector research communities worldwide to facilitate the discovery and development of new cancer therapeutic agents.". https://dtp.cancer.gov/dtpstandard/s... (accessed September 17, 2018).
European Chemicals Agency - ECHA. "Ketamine: The information provided here is aggregated from the "Notified classification and labelling" from ECHA's C&L Inventory. ". https://echa.europa.eu/information-o... (accessed September 17, 2018).
The results of a survey conducted on ndrugs.com for Keta-Hameln are given in detail below. The results of the survey conducted are based on the impressions and views of the website users and consumers taking Keta-Hameln. We implore you to kindly base your medical condition or therapeutic choices on the result or test conducted by a physician or licensed medical practitioners.
Consumer reported side effects
No survey data has been collected yet
There are no reviews yet. Be the first to write one!